Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Sana Biotechnology, the secretive startup, lays (some) cards on the table

  • Kate Sheridan

By Kate Sheridan June 23, 2020

Reprints
Unicorn Stocks
Adobe

After years of rumors, Sana Biotechnology is officially biotech’s newest unicorn.

The company announced Tuesday that it has raised $700 million — one of the largest initial financing rounds for a biotech startup ever. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

Vote now in STAT Madness 2023
Vote now in STAT Madness 2023
Flawed herpes testing leads to many false positives —…
Flawed herpes testing leads to many false positives — and needless suffering
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Solicitor general urges Supreme Court to review ‘skinny labeling’…
Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access
Drug middlemen switch tactics, but the outcome is the…
Drug middlemen switch tactics, but the outcome is the same: high prices
Listen: Biotech’s monkey shortage, the broken generics market, &…
Listen: Biotech’s monkey shortage, the broken generics market, & conference cancel culture

Recommended Stories